MSD Keytruda QLEX™ has been approved in Japan and can be injected subcutaneously to cover all indications for which Keytruda® has been approved in Japan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.